BlogMetro Is So Retro – C. diff Guidelines

Metro Is So Retro – C. diff Guidelines

One Comment

  1. Not sure I buy the evidence base for these guideline updates. The data on fidaxomicin comes from one trial in which the conflict of interest statement is longer than the references-basically the whole trial was run and written up by the manufacturer. Similarly I’m not sure I’ve seen evidence that vanco is "better enough" than metro to justify the change in first line management.

Leave a Reply